Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

First PDE4 inhibitor for psoriasis hits the market but impact is uncertain

Nature Biotechnology volume 32, pages505–506(2014)Cite this article

Subjects

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

Author information

Affiliations

  1. Boca Raton, Florida

    Mark Ratner

Authors
  1. Mark Ratner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ratner, M. First PDE4 inhibitor for psoriasis hits the market but impact is uncertain. Nat Biotechnol 32, 505–506 (2014). https://doi.org/10.1038/nbt0614-505

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing